GLYMAXAN Trademark

Trademark Overview


On Monday, February 10, 2020, a trademark application was filed for GLYMAXAN with the United States Patent and Trademark Office. The USPTO has given the GLYMAXAN trademark a serial number of 88791393. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, January 8, 2021. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The GLYMAXAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain, cardiovascular diseases, respiratory diseases, central nervous system disorders, gastrointestinal diseases, and metabolic syndrome; Pharmaceutical preparations, namely, anti-viral agents, immunosuppressant agents, and corticosteroids; pharmaceutical preparations for use in oncology and endocrinology; pharmaceutical preparations for use in women's health, namely, for the treatment of breast cancer and post-menopausal symptoms; oral contraceptives
glymaxan

General Information


Serial Number88791393
Word MarkGLYMAXAN
Filing DateMonday, February 10, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, January 8, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of pain, cardiovascular diseases, respiratory diseases, central nervous system disorders, gastrointestinal diseases, and metabolic syndrome; Pharmaceutical preparations, namely, anti-viral agents, immunosuppressant agents, and corticosteroids; pharmaceutical preparations for use in oncology and endocrinology; pharmaceutical preparations for use in women's health, namely, for the treatment of breast cancer and post-menopausal symptoms; oral contraceptives

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454

Trademark Events


Event DateEvent Description
Friday, January 8, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, January 8, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, June 26, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, June 26, 2020FINAL REFUSAL E-MAILED
Friday, June 26, 2020FINAL REFUSAL WRITTEN
Wednesday, May 27, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 27, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 27, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 18, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 18, 2020NON-FINAL ACTION E-MAILED
Wednesday, March 18, 2020NON-FINAL ACTION WRITTEN
Monday, March 16, 2020ASSIGNED TO EXAMINER
Friday, February 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 13, 2020NEW APPLICATION ENTERED IN TRAM